UTHR Sale Disclosure
Mahon Paul A · SEC Form 4 · Filed Aug 21, 2026
Sale
Calculated transaction value
$410.82K
Mahon Paul A EVP & General Counsel
UTHR
Transaction date
Aug 20, 2026
Public filing date
Aug 21, 2026
Filing lag
Filed 1 day later
UTHR daily price context
Close on/before transaction
$521
Aug 20, 2026
Close before public filing
$521
Aug 20, 2026
Return since public filing
-4.59%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 787 shares @ $522
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001231589-26-000018
Filing cohort
Transactions in this filing
Showing 13 of 13
Trades
13
Issuers
1
Estimated value
$5.55M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| United Therapeutics Corp UTHR | Exercise | Aug 20, 2026 | $392.82K |
| United Therapeutics Corp UTHR | Exercise | Aug 20, 2026 | $819.23K |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $1.41M |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $261.06K |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $947.77K |
| United Therapeutics Corp UTHR Current | Sale | Aug 20, 2026 | $410.82K |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $444.37K |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $100.55K |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $493.74K |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $210.55K |
| United Therapeutics Corp UTHR | Sale | Aug 20, 2026 | $63.27K |
| United Therapeutics Corp UTHR | Exercise | Aug 20, 2026 | $0 |
| United Therapeutics Corp UTHR | Exercise | Aug 20, 2026 | $0 |